We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants

Delisted

NSPRZ was delisted on the 14th of March, 2022.

5 hedge funds and large institutions have $74K invested in InspireMD, Inc. Series B Warrants in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 55 (0)

48% less capital invested

Capital invested by funds: $142K → $74K (-$68K)

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$40K +$33 +1,200 +0.1%
AFM
2
Anson Funds Management
Texas
$32K
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$2K
UBS Group
4
UBS Group
Switzerland
+$3 +100 +2%
VF
5
Virtu Financial
New York
+$434 +16,033 +23%

NSPRZ Hedge Fund Activity: Q4 2017 in Review

5 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q4 2017, worth a combined $74K — down 48% from $142K a quarter earlier.

Fund positioning in NSPRZ was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was Virtu Financial, adding an estimated $434.

  • 5 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $74K of InspireMD, Inc. Series B Warrants stock for Q4 2017, down 48% quarter-over-quarter.
  • 0 funds opened new InspireMD, Inc. Series B Warrants positions in Q4 2017 and 0 closed out.
  • The largest InspireMD, Inc. Series B Warrants buyer in Q4 2017 was Virtu Financial, an estimated $434 added.

Based on aggregated 13F filings for Q4 2017.